Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • Bitcoin USD

    60,578.81
    -1,909.45 (-3.06%)
     

  • CMC Crypto 200

    1,302.78
    -55.23 (-4.07%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • Dow

    39,512.84
    +125.08 (+0.32%)
     

  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     

  • Gold

    2,366.90
    +26.60 (+1.14%)
     

  • Crude Oil

    78.20
    -1.06 (-1.34%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

EU regulators halt review of Zimmer's $13 billion Biomet bid

Reuters

BRUSSELS (Reuters) - The European Commission halted its review of Zimmer Holdings Inc's $13.4 billion (7.97 billion pounds) bid for Biomet Inc [LVBHAB.UL] on Thursday, saying the U.S. orthopedic products maker's submission lacked some details.

Zimmer sought European Union clearance on June 3 for the deal that would make it the second-biggest in the sector, behind market leader Johnson & Johnson.

"The notification that the Commission received was incomplete," Commission spokesman for competition policy Antoine Colombanni said.

The watchdog scrapped its July 9 deadline for a decision on the deal and will set a new date once Zimmer provides the required data.

(Reporting by Foo Yun Chee; Editing by Erica Billingham)